• 2001-2021
    KEEP LIFE FLOWING

    Learn more

  • WATCH THE INTERVIEW

    Val Romberg, CEO of Kedrion Biopharma, explains how our company is working on cultural change, and efficiency and business program improvements. Watch the interview online on "Le Fonti TV".

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
04-06-2021
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
01-04-2021
First patient enrolled in KIDCARES10
Kedrion Biopharma Pediatric Primary Immunodeficiency Study
Read all
04-01-2021
Kedrion Biopharma Phase III Trial, CARES10, achieves important milestone
Kedrion Biopharma, an international biopharmaceutical company specialized in the manufacture and distribution of plasma-derived therapeutic products used in treating rare and serious diseases.
Read all
Pharmacovigilange
Medical & Scientific Information
2020 Annual report